Achieve Life Sciences (ACHV) Assets Average (2016 - 2026)
Achieve Life Sciences (ACHV) has disclosed Assets Average for 16 consecutive years, with $37.4 million as the latest value for Q1 2026.
- Quarterly Assets Average rose 13.49% to $37.4 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $37.4 million through Mar 2026, up 13.49% year-over-year, with the annual reading at $40.2 million for FY2025, 38.65% up from the prior year.
- Assets Average for Q1 2026 was $37.4 million at Achieve Life Sciences, down from $46.9 million in the prior quarter.
- The five-year high for Assets Average was $67.4 million in Q2 2024, with the low at $21.9 million in Q4 2023.
- Average Assets Average over 5 years is $39.0 million, with a median of $37.4 million recorded in 2026.
- The sharpest move saw Assets Average tumbled 42.39% in 2023, then soared 171.2% in 2024.
- Achieve Life Sciences' Assets Average stood at $26.8 million in 2022, then dropped by 18.6% to $21.9 million in 2023, then soared by 98.02% to $43.3 million in 2024, then grew by 8.41% to $46.9 million in 2025, then fell by 20.18% to $37.4 million in 2026.
- Per Business Quant, the three most recent readings for ACHV's Assets Average are $37.4 million (Q1 2026), $46.9 million (Q4 2025), and $55.5 million (Q3 2025).